Ross Stewart
- Oncology top 1%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Robert W. WilkinsonMichelle MorrowEdmund PoonSimon J. DovediJamie HoneychurchTim IllidgeEleanor J. CheadleGrazyna Lipowska‐Bhalla
- Topics
- Cancer Immunotherapy and Biomarkers (23 papers)Immunotherapy and Immune Responses (8 papers)PARP inhibition in cancer therapy (7 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
Ross Stewart
44 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 1.9k
- Immunology 842
- Pulmonary and Respiratory Medicine 631
- Molecular Biology 378
- Radiology, Nuclear Medicine and Imaging 338
Countries citing papers authored by Ross Stewart
This map shows the geographic impact of Ross Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Stewart more than expected).
Fields of papers citing papers by Ross Stewart
This network shows the impact of papers produced by Ross Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Stewart. The network helps show where Ross Stewart may publish in the future.
Co-authorship network of co-authors of Ross Stewart
This figure shows the co-authorship network connecting the top 25 collaborators of Ross Stewart. A scholar is included among the top collaborators of Ross Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Stewart. Ross Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 15 | |
| 7 | 21 | |
| 8 | 8 | |
| 9 | 23 | |
| 10 | 25 | |
| 11 | 23 | |
| 12 | 38 | |
| 13 | Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trialbreakdown → | 160 |
| 14 | 5 | |
| 15 | 263 | |
| 16 | 59 | |
| 17 | 76 | |
| 18 | Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockadebreakdown → | 974 |
| 19 | 3 | |
| 20 | 20 |
About Ross Stewart
Ross Stewart is a scholar working on Oncology, Immunology and Hepatology, having authored 46 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (8 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (842 citations) and Pulmonary and Respiratory Medicine (631 citations). Ross Stewart has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include Robert W. Wilkinson, Michelle Morrow, Edmund Poon, Simon J. Dovedi, Jamie Honeychurch, Tim Illidge, Eleanor J. Cheadle, Grazyna Lipowska‐Bhalla, Amy L. Adlard and Ian J. Stratford. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.